The molecular biology of Huntington's disease
The molecular biology of Huntington's disease
Background. Huntington's disease (HD) is a fatal neurodegenerative disorder with an autosomal dominant mode of inheritance. It leads to progressive dementia, psychiatric symptoms and an incapacitating choreiform movement disorder, culminating in premature death. HD is caused by an increased CAG repeat number in a gene coding for a protein with unknown function, called huntingtin. The trinucleotide CAG codes for the amino acid glutamine and the expanded CAG repeats are translated into a series of uninterrupted glutamine residues (a polyglutamine tract).
Methods. This review describes the epidemiology, clinical symptomatology, neuropathological features and genetics of HD. The main aim is to examine important findings from animal and cellular models and evaluate how they have enriched our understanding of the pathogenesis of HD and other diseases caused by expanded polyglutamine tracts.
Results. Selective death of striatal and cortical neurons occurs. It is likely that the HD mutation confers a deleterious gain of function on the protein. Neuronal intranuclear inclusions containing huntingtin and ubiquitin develop in patients and transgenic mouse models of HD. Other proposed mechanisms contributing to neuropathology include excitotoxicity, oxidative stress, impaired energy metabolism, abnormal protein interactions and apoptosis.
Conclusions. Although many interesting findings have accumulated from studies of HD and other polyglutamine diseases, there remain many unresolved issues pertaining to the exact roles of intranuclear inclusions and protein aggregates, the mechanisms of selective neuronal death and delayed onset of illness. Further knowledge in these areas will inspire the development of novel therapeutic strategies.
3-14
Ho, L.W.
15fd89cb-be65-4d19-bf27-66a168b52c8b
Carmichael, J.
514345ff-3157-4f8f-8d5f-234728feebe0
Swartz, J.
c6b73317-135f-4e75-8166-8dcb2ae4a92b
Wyttenbach, A.
69846a0f-fb60-4a28-84eb-ed865a5e31fa
Rankin, J.
f46fdd1f-6006-4a21-ace2-b4d8d8c85c20
Rubinsztein, D.C.
7bc49386-aa67-4658-a966-0d952e6fd731
1 January 2001
Ho, L.W.
15fd89cb-be65-4d19-bf27-66a168b52c8b
Carmichael, J.
514345ff-3157-4f8f-8d5f-234728feebe0
Swartz, J.
c6b73317-135f-4e75-8166-8dcb2ae4a92b
Wyttenbach, A.
69846a0f-fb60-4a28-84eb-ed865a5e31fa
Rankin, J.
f46fdd1f-6006-4a21-ace2-b4d8d8c85c20
Rubinsztein, D.C.
7bc49386-aa67-4658-a966-0d952e6fd731
Ho, L.W., Carmichael, J., Swartz, J., Wyttenbach, A., Rankin, J. and Rubinsztein, D.C.
(2001)
The molecular biology of Huntington's disease.
Psychological Medicine, 31 (1), .
Abstract
Background. Huntington's disease (HD) is a fatal neurodegenerative disorder with an autosomal dominant mode of inheritance. It leads to progressive dementia, psychiatric symptoms and an incapacitating choreiform movement disorder, culminating in premature death. HD is caused by an increased CAG repeat number in a gene coding for a protein with unknown function, called huntingtin. The trinucleotide CAG codes for the amino acid glutamine and the expanded CAG repeats are translated into a series of uninterrupted glutamine residues (a polyglutamine tract).
Methods. This review describes the epidemiology, clinical symptomatology, neuropathological features and genetics of HD. The main aim is to examine important findings from animal and cellular models and evaluate how they have enriched our understanding of the pathogenesis of HD and other diseases caused by expanded polyglutamine tracts.
Results. Selective death of striatal and cortical neurons occurs. It is likely that the HD mutation confers a deleterious gain of function on the protein. Neuronal intranuclear inclusions containing huntingtin and ubiquitin develop in patients and transgenic mouse models of HD. Other proposed mechanisms contributing to neuropathology include excitotoxicity, oxidative stress, impaired energy metabolism, abnormal protein interactions and apoptosis.
Conclusions. Although many interesting findings have accumulated from studies of HD and other polyglutamine diseases, there remain many unresolved issues pertaining to the exact roles of intranuclear inclusions and protein aggregates, the mechanisms of selective neuronal death and delayed onset of illness. Further knowledge in these areas will inspire the development of novel therapeutic strategies.
This record has no associated files available for download.
More information
Published date: 1 January 2001
Identifiers
Local EPrints ID: 56354
URI: http://eprints.soton.ac.uk/id/eprint/56354
ISSN: 0033-2917
PURE UUID: df9f9395-81d3-45a2-b455-5e2fffed69c4
Catalogue record
Date deposited: 08 Aug 2008
Last modified: 08 Jan 2022 13:04
Export record
Contributors
Author:
L.W. Ho
Author:
J. Carmichael
Author:
J. Swartz
Author:
A. Wyttenbach
Author:
J. Rankin
Author:
D.C. Rubinsztein
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics